Last update 26 Dec 2024
IBR-733
Last update 26 Dec 2024
Overview
Basic Info
Drug Type CAR-NK |
Synonyms Anti-CLL1/CD33 CAR T Cell(Guangzhou Bio-gene Technology), CLL1/CD33 CAR-T(Guangzhou Bio-gene Technology), IBR733 |
Target |
Mechanism CD33 modulators(Myeloid cell surface antigen CD33 modulators), CLL-1 modulators(C-Type lectin domain family 12 member A modulators), Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with IBR-733一项评价IBR733细胞注射液治疗急性髓系白血病的安全性、耐受性及初步疗效的开放、多中心I期临床研究
[Translation] An open, multicenter phase I clinical study to evaluate the safety, tolerability and preliminary efficacy of IBR733 cell injection in the treatment of acute myeloid leukemia
Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in Refractory/Recurrent Acute Myeloid Leukemia: a Single-arm, Non-blind Clinical Study
A Single-arm, Open-label, Single-center Clinical Study: Safety, Tolerability and Preliminary Efficacy of Autologous Anti-CLL1/CLL1+CD33 CAR-T in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
100 Clinical Results associated with IBR-733
Login to view more data
100 Translational Medicine associated with IBR-733
Login to view more data
100 Patents (Medical) associated with IBR-733
Login to view more data
100 Deals associated with IBR-733
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | CN | 02 Apr 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free